NASDAQ$MASS

908 Devices Inc · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Briefing

Reported a 34% increase in revenue compared to the prior year, with a gross margin of 60%.

908 Devices reported an $11.1 million revenue for Q2 2022, a 34% increase year-over-year. The gross margin was 60%, and the company experienced a net loss of $8.1 million. They have acquired TRACE Analytics, expanding their bioanalytics platform.

  • Revenue for Q2 2022 was $11.1 million, a 34% increase compared to the prior year period.
  • Desktop revenue grew by 39% year-over-year driven by increased device sales and recurring revenue.
  • Gross profit for Q2 2022 was $6.6 million, with a gross margin of 60%.
  • Net loss for Q2 2022 was $8.1 million, or $0.26 per share.

Headline financials

Total Revenue

$11.1M

Previous: $8.28M+34.2%
EPS (adj)

-$0.26

Previous: -$0.27+3.7%
Installed Base

2.1K

No prior period
Devices Placed

124

No prior period
Capital Expenditures

-$689K

Previous: -$625K-10.2%
Free Cash Flow

-$8.79M

Previous: -$8.05M-9.2%
Net Income

-$8.1M

Previous: -$7.42M-9.1%
Operating Income

-$8.37M

Previous: -$7.46M-12.3%
Gross Profit

$6.63M

Previous: $4.38M+51.5%
Cash & Equivalents

$213M

Previous: $141M+50.7%
Total Assets

$247M

Previous: $166M+48.4%
Stock-Based Comp

$1.89M

Previous: $481K+293.8%

Revenue & EPS history

908 Devices · Revenue · Quarterly

$11.1M

Q2 2022+34.2%vs Q2 2021
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Forward guidance

908 Devices continues to expect full year 2022 revenue to be in the range of $52 million to $55 million, representing 23% to 30% growth over full year 2021.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2022

Historical avgQ2 2022

+1.3%

Avg return

Earnings day

-2.9%

Avg return

5 days after

+2.8%

Avg return

30 days after

46%

11 / 24 earnings

Positive

+96.0%

Q4 2024

Best reaction

-35.4%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+13.7%+11.8%+11.8%
Q4 2025-4.8%-5.3%+0.0%
Q3 2025-13.2%-25.7%-10.8%
Q1 2025-18.9%-20.1%+25.5%
Q4 2024+96.0%+39.4%+88.9%
Q3 2024-35.4%-34.0%-41.4%
Q2 2024-5.0%-6.0%-21.6%
Q1 2024-1.4%-1.8%+7.0%
Q4 2023-1.1%-5.1%-10.1%
Q3 2023-4.9%-11.2%+23.0%
Q2 2023+17.7%+15.0%+8.1%
Q1 2023+8.4%+4.8%+28.6%
Q4 2022+0.3%-10.6%-5.5%
Q3 2022-34.4%-38.2%-44.4%
Q2 2022-8.9%-9.9%-7.6%
Q1 2022-12.6%+6.6%-5.5%
Q4 2021+12.8%+17.2%+24.7%
Q3 2021+14.7%+2.7%-30.0%
Q3 2020+14.7%+2.7%-30.0%
Q2 2021+9.4%+5.4%+26.2%
Q2 2020+9.4%+5.4%+26.2%
Q1 2021-16.3%-14.6%-7.3%
Q1 2020-16.3%-14.6%-7.3%
Q4 2020+7.8%+15.8%+18.0%
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro